Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cornell University Veterinary Investigator Program
Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training
Spectral Enhancement of Speech
Biophysical Regulation of Chondrocyte Differentiation
Structure/Function of Cyclin Dependent Kinases
Recently added grants:
Utilizing single-cell Massively Parallel Reporter Assays to dissect gene by environment interactions
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
Childhood Cancer Survivor Study
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-002
Application #
6828860
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant